InsidersTradesSigma
Follow the Enhabit, Inc. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Enhabit, Inc. has published 251 reports. Market capitalisation: €706.9m. The latest transaction was disclosed on 15 May 2026 (Disposition). Among the most active insiders: Bolton Jeffrey. Every trade is openly available.
251
Insider Decl.
n/a
Thresholds
€2m
30 ops.
Buy Volume
€26m
32 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Enhabit, Inc. Hold (neutral), based on 5 analysts. Average price target: US$13.80.
47Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,359 of 29,064 companies
40.9
score / 100
Value48
Quality34
FCF yld9.3%
Earn yld-0.7%
EV/EBITDA15.0x
ROE-0.2%
Gross mgn49%
Net mgn-0.4%
Debt/EBITDA6.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 15 May 2026
Declarations251 total
34,413 shares@ US$13.800.087% mcap9.6% of flowCommon StockSEC:0001966580-26-000008:3
49,601 shares@ US$13.800.13% mcap13.9% of flowCommon StockSEC:0001966580-26-000008:5
24,072 shares@ US$13.800.061% mcap6.7% of flowCommon StockSEC:0001966580-26-000008:7
58,560 shares@ US$13.800.15% mcap16.4% of flowCommon StockSEC:0001966580-26-000008:1
34,413 shares@ US$13.800.087% mcap9.6% of flowCommon StockSEC:0001966580-26-000008:2
49,601 shares@ US$13.800.13% mcap13.9% of flowCommon StockSEC:0001966580-26-000008:4
24,072 shares@ US$13.800.061% mcap6.7% of flowCommon StockSEC:0001966580-26-000008:6
48,000 shares@ US$13.800.12% mcap28.2% of flowCommon StockSEC:0001925331-26-000007:1
80,682 shares@ US$13.800.20% mcap47.5% of flowCommon StockSEC:0001925331-26-000007:2
51,148 shares@ US$13.800.13% mcap75.3% of flowCommon StockSEC:0001937414-26-000002:1
73,412 shares@ US$13.800.19% mcap70.9% of flowCommon StockSEC:0001122124-26-000006:1
64,605 shares@ US$13.800.16% mcap71.1% of flowCommon StockSEC:0001205444-26-000007:1
70,338 shares@ US$13.800.18% mcap67.8% of flowCommon StockSEC:0001328255-26-000006:1
60,466 shares@ US$13.800.15% mcap59.3% of flowCommon StockSEC:0001335234-26-000006:1
69,305 shares@ US$13.800.18% mcap61.9% of flowCommon StockSEC:0001653488-26-000006:1
65,964 shares@ US$13.800.17% mcap2.9% of flowCommon StockSEC:0001691132-26-000006:1
127,129 shares@ US$13.800.32% mcap5.6% of flowCommon StockSEC:0001691132-26-000006:2
263,237 shares@ US$13.800.67% mcap11.6% of flowCommon StockSEC:0001691132-26-000006:3
263,237 shares@ US$13.800.67% mcap11.6% of flowCommon StockSEC:0001691132-26-000006:4
340,530 shares@ US$13.800.86% mcap15.1% of flowCommon StockSEC:0001691132-26-000006:5
340,530 shares@ US$13.800.86% mcap15.1% of flowCommon StockSEC:0001691132-26-000006:6
23,575 shares@ US$13.800.060% mcap50.0% of flowCommon StockSEC:0001933994-26-000009:0
7,325 shares@ US$13.800.019% mcap50.0% of flowCommon StockSEC:0001205444-26-000007:0
15,000 shares@ US$13.800.038% mcap50.0% of flowCommon StockSEC:0001335234-26-000006:0
73,591 shares@ US$13.800.19% mcap50.0% of flowCommon StockSEC:0001933957-26-000010:0
25 of 251 declarations
关于 Enhabit, Inc.
Enhabit, Inc. 是一家总部位于美国的医疗保健公司，在纽约证券交易所上市，股票代码为 EHAB。Enhabit 总部位于德克萨斯州达拉斯，业务涵盖家庭健康和临终关怀市场，该市场受到美国长期人口结构和报销趋势的支持。该公司成立于 1998 年，于 2022 年 7 月 1 日从 Encompass Health Corporation 分拆后成为一家独立的上市公司。([sec.gov](https://www.sec.gov/Archives/edgar/data/1803737/000180373726000018/ehab-20251231.htm?utm_source=openai)) Enhabit 的商业模式围绕两个核心服务线构建。其家庭健康部门提供在患者家中进行的临床护理，包括术后康复支持、疾病和损伤管理、慢性病监测以及协调治疗服务。其临终关怀部门专注于以舒适为导向的临终护理，为绝症患者及其家人提供医疗、情感和精神支持。这些业务共同使 Enhabit 能够接触到更广泛的居家护理连续体，这种护理模式越来越受到患者、提供者和支付方的青睐，他们都在寻求比住院环境成本更低的替代方案。([enhabit.com](https://www.enhabit.com/about-us/?utm_source=openai)) 从地理角度来看，该公司在 34 个州拥有全国性的业务。Enhabit 强调其广泛的家庭健康和临终关怀网络，这有助于其与医院、医生、健康计划和其他护理合作伙伴保持转诊关系。该业务依靠当地临床团队、运营密度和技术支持的护理服务，以大规模支持患者结果和服务质量。([enhabit.com](https://www.enhabit.com/about-us/?utm_source=openai)) 在竞争方面，Enhabit 在一个分散的行业中定位为一家规模化的全国性提供商，该行业包括区域机构、私人运营商以及扩展到居家护理的更大医疗保健系统。其差异化在于其专注于家庭健康和临终关怀的专业领域、其全国范围以及其在一个平台下管理两个互补服务线的能力。该公司还强调其以患者为中心的文化和临床专业知识是其市场定位的关键部分。([enhabit.com](https://www.enhabit.com/about-us/?utm_source=openai)) 近期发展对股权投资者而言至关重要。在 2025 年和 2026 年 3 月，Enhabit 报告了收入、患者人数和调整后 EBITDA 的改善，同时努力加强自由现金流和资产负债表。最值得注意的是，在 2026 年 1 月 23 日，该公司宣布与 Kinderhook Capital 达成最终协议，以每股 13.80 美元的现金收购，这意味着企业价值约为 1.1 billion 美元。这项交易是 Enhabit 近期最重要的公司事件，也是评估其在美国纽约证券交易所股票的主要因素。([sec.gov](https://www.sec.gov/Archives/edgar/data/1803737/000180373726000015/q42025enhabitearningsrelea.htm?utm_source=openai))
